Katayoun Welin Berger, BioGaia's Vice President Operations, tells us about the activities of the company.
The microbiome may be a source for biomarkers leading to therapeutic discoveries and diagnostics. We discuss it with Emily Hollister, Vice President of Diversigen.
Richard Ellis, Head of Business Development at Biose, explains how CDMO companies assist start-ups in bringing live biotherapeutic products to the market.
Travis Whitfill, Co-Founder and CSO of Azitra, explains how Staphylococcus epidermidis-based products may treat various skin conditions and diseases.
Probiotics: 2019 will be crucial for scientific and regulatory aspects with help coming also from Venture Capital. Denise Kelly from Seventure talks about it.
The development of probiotics presents major regulatory challenges. We discussed it this Clara Desvignes from Voisin Consulting Life Sciences.
New technologies such as the analysis of the "aquatic microbiota" allow to dig deeply into the microbiome chemistry. We discuss this approach with Ross Youngs, CEO of Biosortia.
Stay in Touch
MicrobiomePost supports the microbiome community by connecting business, investors, academy, industry and science key opinion leaders.
Specific food dyes are environmental risk factors for colitis development in conditions where IL-23 expression is dysregulated.
A new study published in Cell Host & Microbe claims that the infant gut is home to bacteria that harbor hundreds of antibiotic-resistance genes.
Advisor to the Director General Romano Marabelli presents the role of the World Organisation for Animal Health at this year's Probiotics, Prebiotics & New Foods...
A new study published in Cell Host & Microbe could pave the way for using phages as biomarkers for the condition of rheumatoid arthritis.